Latigo Biotherapeutics, Inc.

NAS:LTGOHealth Technologynasdaq_composite

$14.30+2.14%At closeAt close · Tue 20 Oct · ≈ AED 52.52 · Market cap — · Next earnings Wed 2 Dec

Latigo Biotherapeutics, Inc. · Valuation · TradingHolo

ⓘ

Valuation is not comparable for this issuer, so multiples are hidden. Use Forecasts and Financials for the underlying drivers.

Same market and sector · market cap in USD

Company	Price	Change	Mkt cap (USD)	P/E	ROE	1Y
NAS:BRVEBraveheart Bio Inc · 🇺🇸 NAS	$19.21	+2.67%	$1.73B	—	−78.6%	—
NAS:KRSAKorsana Biosciences Inc · 🇺🇸 NAS	$31.41	−3.00%	$1.43B	—	−38.8%	+1296.0%
NAS:CTYCity Therapeutics, Inc. · 🇺🇸 NAS	$21.46	−4.20%	$1.08B	—	69.1%	—
NAS:OBXObsidian Therapeutics Inc · 🇺🇸 NAS	$11.94	+1.44%	$737.57M	—	2,275.2%	—
NAS:ATTOAttovia Therapeutics Inc · 🇺🇸 NAS	$13.89	+1.17%	$634.1M	—	−40.4%	—
NAS:BLSMBlossomHill Therapeutics Inc · 🇺🇸 NAS	$14.16	+1.58%	$450.07M	—	46.0%	—
NAS:VOGXVogenx Inc · 🇺🇸 NAS	$15.92	+9.57%	$236.49M	—	157.3%	—
NAS:CNSYCerenome, Inc. · 🇺🇸 NAS	$1.65	−2.94%	$12.52M	—	−560.2%	+168.7%
NAS:EOCNEocene Ltd. · 🇺🇸 NAS	$2.85	+0.00%	$2.97M	—	−65.3%	+102.1%
NAS:BSEMBioStem Technologies, Inc. · 🇺🇸 NAS	$1.54	−26.32%	—	—	−16.8%	−67.3%